Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2007 Jul;254(7):931-40.
doi: 10.1007/s00415-006-0432-4. Epub 2007 Mar 14.

Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy

Affiliations
Randomized Controlled Trial

Effects of training and albuterol on pain and fatigue in facioscapulohumeral muscular dystrophy

E L van der Kooi et al. J Neurol. 2007 Jul.

Abstract

Background: We recently reported a randomised controlled trial on the efficacy of strength training and the beta2-adrenergic agonist albuterol in patients with facioscapulohumeral muscular dystrophy (FSHD). Strength training and albuterol appeared safe interventions with limited positive effect on muscle strength and volume. We concurrently explored the prevalence and the characteristics of pain and fatigue in the participating FSHD patients, because these are probably underreported but clinically relevant symptoms in this disorder. Next, we studied the effects of albuterol and strength training on pain, experienced fatigue, health-related functional status and psychological distress.

Methods: Sixty-five patients were randomised to strength training of elbow flexors and ankle dorsiflexors or non-training. After 26 weeks, albuterol (sustained-release, 8 mg bid) was added in a randomised, double-blind, placebo-controlled design. Outcomes comprised self-reported pain, experienced fatigue, functional status and psychological distress obtained with validated questionnaires at 52 weeks.

Results: Eighty percent of patients reported chronic persistent or periodic, multifocal pains. Thirty-four percent of the participants were severely fatigued. Strength training and albuterol failed to have a significant effect on all outcomes.

Conclusions: Pain and fatigue are important features in FSHD. Strength training and albuterol do not have a positive or negative effect on pain, experienced fatigue, functional status and psychological distress.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Study design and flow of patients through each stage of the study. NT = non-training group, T = training group, P = placebo, and A = albuterol

References

    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/0003-9993(93)90031-5', 'is_inner': False, 'url': 'https://doi.org/10.1016/0003-9993(93)90031-5'}, {'type': 'PubMed', 'value': '8328892', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/8328892/'}]}
    2. Aitkens SG, McCrory MA, Kilmer DD, Bernauer EM (1993) Moderate resistance exercise program: its effect in slowly progressive neuromuscular disease. Arch Phys Med Rehabil 74:711–715 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '9624661', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/9624661/'}]}
    2. American College of Sports Medicine Position Stand (1998) The recommended quantity and quality of exercise for developing and maintaining cardiorespiratory and muscular fitness, and flexibility in healthy adults. Med Sci Sports Exerc 30:975–991 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1097/00005768-200202000-00027', 'is_inner': False, 'url': 'https://doi.org/10.1097/00005768-200202000-00027'}, {'type': 'PubMed', 'value': '11828249', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11828249/'}]}
    2. American College of Sports Medicine Position Stand (2002) Progression models in resistance training for healthy adults. Med Sci Sports Exerc 34:364–380 - PubMed
    1. {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1002/mus.880181312', 'is_inner': False, 'url': 'https://doi.org/10.1002/mus.880181312'}, {'type': 'PubMed', 'value': '7739627', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/7739627/'}]}
    2. Arahata K, Ishihara T, Fukunaga H, et al. (1995) Inflammatory response in facioscapulohumeral dystrophy (FSHD): immunocytochemical and genetic analysis. Muscle Nerve 2:S56–S66 - PubMed
    1. Arindell WA, Ettema JHM (1986) SCL- 90, handleiding bij multidimensionele psychopathologie-indicator. Swets & Zeitlinger BV, Amsterdam

Publication types

MeSH terms